26 hours ago The purpose of this case report was to describe the acute and inpatient rehabilitation (IPR) examination, interventions, and outcomes for a patient with breast cancer and … >> Go To The Portal
Running over 28hrs, the PORi Breast Cancer Rehabilitation continuing education course includes patient case presentations of patients who have undergone a variety of treatments for breast cancer and present with a variety of conditions and side-effects relating to their cancer treatments.
Implement a breast cancer rehabilitation program into their clinical practice using key PORI algorithms, PORI protocols, and evidence-based clinical practice presented in the course manual that is within the scope of professional practice
Breast-conserving surgery with subsequent chemo-radiotherapy has become the treatment of choice in women with breast neoplasm. Case report: Two young patients, 30 and 28 years respectively, with breast cancer.
Patient followed-up with physical therapist with MD diagnosis of Stage 2 Breast Cancer. Due to pt’s family history of breast cancer, MD performed clinical breast examination followed by a mammogram. Tumor was found in R breast tissue but has not spread to lymph nodes or other surrounding organs.
Implement a breast cancer rehabilitation program into their clinical practice using key PORI algorithms, PORI protocols, and evidence-based clinical practice presented in the course manual that is within the scope of professional practice
Running over 28hrs, the PORi Breast Cancer Rehabilitation continuing education course includes patient case presentations of patients who have undergone a variety of treatments for breast cancer and present with a variety of conditions and side-effects relating to their cancer treatments. For virtual courses, patient presentations will run from between 60 minutes and 90 minutes via pre-recorded videos of patient treatments, technique demonstrations and patient interviews. In live courses or live lab supplementary courses, a patient case presentation can run as long as 3 hours and participants are given the opportunity, with guided supervision from the instructor, to perform subjective and objective evaluations on these patients, as well as practice the appropriate techniques (presented in the course) on the patients during these lab sessions.
Explain a clinical foundation of management for individual cancer patients using four elements of predictability of care related to tumor behavior (in-situ, invasive, node involvement, and metastatic) based on the AJCC Staging and Grading of cancer pathology.
Careful study is made of the impact of cancer treatment on the Epidermal, Dermal, Myofascial, Skeletal, Lymphatic, Vascular and Neural Systems, and the treatment protocols instructed by PORi relate to the optimal resolution of signs and symptoms within these body systems.
Because the recurrence again appeared to be localized, in July 2002, Janice underwent tertiary debulking surgery, with successful removal of ...
Janice completed her last round of chemotherapy in December of 2002 and today remains cancer-free. Case Highlights: Use of combined PET/CT to diagnose occult recurrence. Use of secondary debulking surgery. Most patients only will be given the option of additional chemotherapy.
Consequently, a different chemotherapy drug (Gemcitabine) was chosen for the third round of treatment.
Janice then had successful secondary cytoreductive surgery in September 2001 to remove the mass and received 6 more cycles ...
Chief Complaint J.W. is a 55-year-old woman recently admitted to the hospital for worsening shortness of breath (Slide 1). Relevant Medical History • Stage 4 estrogen receptor/progesterone receptor–positive breast cancer. Current Treatment Regimen • Nab-paclitaxel 100 mg/m2 on day 1, 8, and 15, repeated every 28 days. and denosumab every 28 days for her bone…
lymph nodes (ALNs) receive 85 percent of the lymphatic drainage from all quadrants of the breast; the remainder drains to the IM chain. The likelihood of ALN involvement is related to tumor size and location, histologic grade, and the presence of lymphatic invasion.
Although there are new therapies for M1CRPC patients and others pending, ideal sequencing regimen is still not certain.
Erman et al [9] reported a woman who developed esophageal metastasis 11 years after breast cancer diagnosis. She survived for 5 years with a combination of radiotherapy, chemotherapy, and hormone therapy.
Esophageal involvement in breast cancer mostly occurs in postmenopausal women. The most common clinical manifestation is dysphagia, ac companied by weight loss, ano rexia, vocal dysfunction, and so on. Patients may not experience dysphagia until 7.1 ± 4.2 years after being diagnosed and treated for breast cancer. [4] Metastatic lesions are typically located in the middle or distal thirds of the esophagus, which may be related to lymph node metastasis. [2] Our patient was a postmenopausal woman with an initial presentation of dysphagia. An upper digestive tract radiograph, CT scan, and endoscopy all suggested stricture in the mid-esophagus.
A 62-year-old woman was admitted due to progressive dysphagia over the course of 3 months. The patient had lost 8 kg, but experienced no diarrhea, hematochezia, or abdominal distension. The patient had no history of malignancy. A physical examination found no abnormalities.
[1] Breast cancer is the most common cancer in females. The most common sites of breast cancer metastasis are the bone, liver, brain, and lung, whereas metastasis to the esophagus is rare. [2] Diagnosis of esophageal stricture due to metastatic breast cancer is often difficult, and most cases are diagnosed by autopsy or surgery. [3] Breast cancer presenting with dysphagia as the first manifestation is rarely reported, as esophageal metastasis typically occurs a long time after diagnosis and treatment of the primary breast tumor. [4]
For patients who have metastatic breast cancer, which cannot be cured, the primary treatment is palliative-intent systemic therapy. Patients with hormone receptor-negative disease can choose cytotoxic chemotherapy, and patients with hormone receptor-positive disease have exhausted endocrine therapy options. [10] .
Thus, in this case, intramural metastasis caused the stricture. Diagnosis of an esophageal stricture due to breast cancer is difficult, as differentiating primary esophageal tumors, benign esophageal strictures, and mediastinal carcinomatosis is not trivial when the lesion is in the submucosa and is surrounded by a normal mucosa.
Breast cancer presenting with dysphagia as the first manifestation is rarely reported, as esophageal metastasis typically occurs a long time after diagnosis and treatment of the primary breast tumor. [4] Here we report a case of metastatic breast cancer to the esophagus with dysphagia as the initial symptom.
Male breast cancer accounts for 1% of all breast cancer cases, and men tend to be diagnosed at an older age than women (mean age is about 67 years). Several risk factors have been identified, such as genetic and hormonal abnormalities.
Invasive ductal carcinoma in young men is extremely rare; the peak incidence is around the seventh decade of life. Risk factors for male breast cancer include genetic factors and hormonal abnormalities. Despite an absence of a familial history of breast cancer, hormonal abnormalities, or a genetic disease, the male patient in the present study developed breast cancer at a very young age. The causative factors in this patient were unable to be definitively identified. The pathophysiology of breast cancer in males is not adequately understood. As more cases of breast cancer in young male patients are investigated, we may be able to gain a better understanding of the mechanism.